BRKR | Bruker corp - Stock Value & PE Ratio Analysis

3

24

15

Good Growth

AI analysis rates BRKR with a higher value score of 4.
Over the past 3 months, BRKR has maintained an average value rating of 3.0, slightly lower than the rating of 3.5 over the past 3 years, indicating decreasing growth opportunities for enterprise value.
Compared to all stocks in the Health Care sector, BRKR has a higher value rating.

BRKR Value Reference Factors

The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.

Update to 2025/02/21 (Weekly Update)

BRKR Financial Forecast

Unit : USD

Update to 2025/5/4 (Quarterly Update)

BRKR Earnings Table

Unit : USD

QTR	Non-GAAP EPS	EPS YoY	EPS Surprise %	Sales	Sales YoY	Sales Surprise %	NPM
Current	0.76	-5%	3.1%	979.6M	14.6%	1.4%	1.4%
2024Q3	0.6	-18.9%	1.1%	864.4M	16.4%	0.6%	4.7%
2024Q2	0.52	4%	-0.6%	800.7M	17.4%	0.5%	0.9%
2024Q1	0.53	-17.2%	14.3%	721.7M	5.3%	-1.1%	7%
2023Q4	0.8	8.1%	17.4%	854.5M	20.6%	5.8%	24%

Update to 2025/5/8 (Quarterly Update)

BRKR Historical Value Score

You can use historical scores of 3 or above to observe potential performance and make investment decisions.

BRKR Value Strategy Backtest

The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.

Entry

Exit

The Backtest Result of BRKR from 2007/01 till Now

848.87%
Cumulative Return: 13.07%
Annual Return: 38.27%
Volatility: 0.34
Sharpe Ratio

Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from January, 2007 to May, 2025. (Total Trades: 3)